MedTech Spectrum

Article Name Predictive Diagnostics

Targeted Battle Against HPV

Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations worldwide. Australia is on track to become one of the first nations to achieve this, and countries like Bangladesh and Indonesia have introduced HPV vaccines. Let's examine Asia's efforts in eliminating cervical cancer and whether the continent is on track to meet WHO’s targets by 2030.

08th January, 2024

Varian & Nova Scotia Health Forge Groundbreaking Oncology Partnership for Cancer Care Advancements

Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship.

05th January, 2024

Urology of Virginia Announces New Chief Executive Officer

Dr. Joshua Langston Assumes Role of Managing Partner and CEO at Urology of Virginia

02nd January, 2024

Lucem Health Launches Reveal for Faster AFib-Related Stroke Treatment

Groundbreaking Solution Identifies Undiagnosed AFib and Speeds Treatments Proven to Prevent Strokes

18th December, 2023

TMRW Life Sciences Expands Globally Entering UK Fertility Market

The Hewitt Fertility Centre is the First UK Clinic to Adopt TMRW's State-of-the-Art Technology for the Safe Management of Frozen Eggs and Embryos Providing a New Standard of Care for Fertility Patients

18th December, 2023

Revvity launches easy-to-use molecular diagnostics workflow for newborn screening

EONIS Q System enabling faster, simplified newborn screening for SMA and SCID

11th December, 2023

BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency

SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success

04th December, 2023

Mayo Clinic Labs and Progentec® Partner for Advanced Autoimmune Biomarker Testing

The collaboration aims to increase accessibility for providers and patients across the U.S. and select global markets.

15th November, 2023

University of Miami Health System to Maximize Patient Care with New Aidoc AI Technology

AI-driven care diagnostic imaging and care coordination to streamline physician workflows for timely and efficient patient care delivery

15th November, 2023

Disruptive Technologies and New Industry Initiatives for Diabetes Management

Asia will continue to be a large and rapidly growing market for diabetes care technologies. To be competitive and successful in the aggressive market with numerous large and startup companies, players will need large funds, a broad portfolio with desirable differentiators and a strong distribution network. Low-cost products, subscription-based solutions, reimbursement policies and training of patients and physicians will be required to promote the adoption among low income and middle-income regions. Large players are very intent on tapping the large market potential in Asia. Many global companies have set up local presence in Asian countries and local production through original equipment manufacturer (OEM) partners in the countries to bring down the cost of their solutions, and more companies are expected to follow

06th November, 2023

Pearl and Gamma Tech Partner to Bring AI to Dentists across Australia and New Zealand

Gamma Tech will distribute Pearl’s flagship AI solution, Second Opinion®, to the ANZ dental markets

02nd November, 2023

Japan-based Shimadzu unveils integrated system for urine volume measurement

Measuring urine volume based on the difference in body weight before and after urination, eliminating the need for urine collection

26th October, 2023

Roche Acquires Telavant and TL1A Antibody for Inflammatory Bowel Disease

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive agreement to acquire Telavant Holdings, Inc. (Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc.

24th October, 2023

Medtronic FDA Approved for Extravascular Defibrillator for Heart Rhythms

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins

24th October, 2023

Redcliffe Labs teams up with RGCB to bolster single-cell genomics in India

This is the second genomics facility to be operated by Redcliffe Labs in India

22nd October, 2023

GE Healthcare and Novo Nordisk Team Up for Non-Invasive Diabetes & Obesity Treatment

GE HealthCare a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity.

20th October, 2023

SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement

SHL Medical ("SHL"), a world-leading solutions provider of advanced drug delivery systems such as autoinjectors and innovative specialty delivery systems, has entered into a non-exclusive co-marketing partnership agreement with Lifecore Biomedical (Nasdaq: LFCR) ("Lifecore"), a fully integrated Contract Development and Manufacturing Organization ("CDMO") that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials.

19th October, 2023